Frugi Biotechnology Inc. received a $256,000 Project Grant award from the National Science Foundation on August 1, 2021 to develop modular, paper-based, secured diagnostics for managing viral outbreaks such as COVID-19. The award is part of the NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and innovation. Under this award, Frugi Biotechnology will leverage its expertise in paper-based diagnostics to create portable, easy-to-use testing solutions for viruses like SARS-CoV-2 that can help public health officials monitor and respond to outbreaks in a timely manner. The project is scheduled to be completed by July 31, 2022.
Generated 1/6/24, 10:14 PM